$349.89
+22.35 (+6.82%)
At Close: Jun 04, 2026
What Happened This Week: FedEx, The ‘Merge’ And Some Mighty Big Losers
01:25pm, Saturday, 17'th Sep 2022 Investing.comHumana (HUM) Gains As Market Dips: What You Should Know
10:15pm, Friday, 16'th Sep 2022 Zacks Investment Research
Humana (HUM) closed at $499.79 in the latest trading session, marking a +0.51% move from the prior day.
Cigna's (CI) Arm Adds Five Digital Health Apps to Its Platform
08:28pm, Friday, 16'th Sep 2022 Zacks Investment Research
Cigna's (CI) unit bolsters its clinical platform Digital Health Formulary by including five on-line solutions, aiming to relieve people from chronic medical conditions.
8 Analysts Have This to Say About Humana
04:35pm, Friday, 16'th Sep 2022 Benzinga
Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
4
3
0
0
Last 30D
0
1
1
0
Oppenheimer Maintains Outperform Rating for Humana: Here's What You Need To Know
04:23pm, Friday, 16'th Sep 2022 Benzinga
Oppenheimer has decided to maintain its Outperform rating of Humana (NYSE:HUM) and raise its price target from $520.00 to $550.00.
Shares of Humana are trading down 0.25% over the last 24 hours, at $4
Humana (HUM) Surges 8.4%: Is This an Indication of Further Gains?
03:23pm, Friday, 16'th Sep 2022 Zacks Investment Research
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
Is Humana (HUM) Stock Undervalued Right Now?
01:40pm, Friday, 16'th Sep 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Company News for Sep 16, 2022
01:40pm, Friday, 16'th Sep 2022 Zacks Investment Research
Companies in The News Are: MSFT, HUM, CTRA, ADBE
HCA Healthcare To Surge About 20%, Plus This Analyst Increases PT On Netflix
12:55pm, Friday, 16'th Sep 2022 Benzinga
Raymond James raised the price target for HCA Healthcare, Inc. (NYSE: HCA) from $230 to $250. HCA Healthcare shares rose 0.4% to close at $208.97 on Thursday.
Oppenheimer boosted the price target on
Humana (HUM) Surges 8.4%: Is This an Indication of Further Gains?
12:48pm, Friday, 16'th Sep 2022
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
Humana (HUM) Hikes Guidance: Here's Why It's a Good Sign
12:13pm, Friday, 16'th Sep 2022 Zacks Investment Research
Humana (HUM) shaking off the discrete COVID-19 headwind from its guidance is an important milestone for the Medical - HMOs space.
Is Humana (HUM) Stock Undervalued Right Now?
11:17am, Friday, 16'th Sep 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Humana (HUM) Hikes Guidance: Here's Why It's a Good Sign
09:47am, Friday, 16'th Sep 2022
Humana (HUM) shaking off the discrete COVID-19 headwind from its guidance is an important milestone for the Medical - HMOs space.
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
08:38am, Friday, 16'th Sep 2022 Benzinga
Gainers
HeartBeam, Inc. (NASDAQ: BEAT) shares jumped 85.6% to close at $2.32 on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of
Dow finishes nearly 200 points lower as Treasury yields rise
08:32pm, Thursday, 15'th Sep 2022 MarketWatch
U.S. stocks finished lower as bond yields rose further Thursday ahead of a likely Federal Reserve interest rate rise next week.
Sign In
Buy HUM